Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.140
+0.230 (12.04%)
At close: Mar 9, 2026, 4:00 PM EDT
2.190
+0.050 (2.34%)
After-hours: Mar 9, 2026, 5:55 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $278.59 million as of March 9, 2026. Its market cap has increased by 591.30% in one year.
Market Cap
278.59M
Enterprise Value
266.75M
1-Year Change
591.30%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $278.59M, a decrease of -7.57%. That is a compound annual growth rate of -0.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 136.00M | 17.14% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 266.14M |
| Cellectis | 265.08M |
| Fennec Pharmaceuticals | 262.98M |
| Abeona Therapeutics | 262.83M |
| Cybin | 262.69M |
| Minerva Neurosciences | 260.08M |
| Inhibikase Therapeutics | 257.15M |
| Surrozen | 252.09M |